GlassScriptPhysician profile
Hai-Ping Mei
NPI 1073567087
$493.76
in general payments reported to CMS, 2019-2025
14 companies · $38.85 in 2025
The $38.85 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $60.78 · 2021: $44.75 · 2022: $37.75 · 2024: $74.57 · 2025: $38.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $113.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $83.02 | 2021-2024 | Xeomin |
| Abbvie INC. | $73.26 | 2022-2025 | |
| Allergan, INC. | $55.52 | 2019-2022 | |
| Merz North America, INC. | $47.39 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $47.17 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $29.78 | 2019 | |
| Arbor Pharmaceuticals, INC. | $26.53 | 2019 | |
| Microtransponder, INC. | $24.24 | 2025 | |
| Celularity INC. | $23.00 | 2019 | |
| Genzyme Corporation | $20.78 | 2020 | |
| Medtronic USA, INC. | $18.55 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $17.93 | 2019 | |
| Assertio Therapeutics, INC. | $14.03 | 2019 | |
| Pacira Therapeutics, INC. | $12.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hai-Ping Mei listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.